The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice-Reference-Cited by-同舟云学术

The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice

Published:2024-05-20 Issue:5 Volume:6 Page:947-962
ISSN:2522-5812
Container-title:Nature Metabolism
language:en
Short-container-title:Nat Metab

Author:

Yun Chuyu^ORCID,Yan Sen^ORCID,Liao Baoying,Ding Yong^ORCID,Qi Xinyu^ORCID,Zhao Min^ORCID,Wang Kai^ORCID,Zhuo Yingying,Nie Qixing,Ye Chuan^ORCID,Xia Pengyan^ORCID,Ma Ming^ORCID,Li Rong^ORCID,Jiang Changtao^ORCID,Qiao Jie^ORCID,Pang Yanli^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s42255-024-01041-8.pdf

Reference65 articles.

1. Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. Lancet 370, 685–697 (2007).

2. Escobar-Morreale, H. F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14, 270–284 (2018).

3. Azziz, R. et al. Polycystic ovary syndrome. Nat. Rev. Dis. Prim. 2, 16057 (2016).

4. Hoeger, K. M., Dokras, A. & Piltonen, T. Update on PCOS: consequences, challenges and guiding treatment. J. Clin. Endocrinol. Metab. 106, e1071–e1083 (2020).

5. Martel, J. et al. Gut barrier disruption and chronic disease. Trends Endocrinol. Metab. 33, 247–265 (2022).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapalink-1 reveals novel mTOR-dependent genes and an agmatinergic axis-based metabolic feedback regulating mTOR activity and lifespan;2024-07-22

2. Does Ozempic boost fertility? What the science says;Nature;2024-06-26

3. A gut punch for PCOS;Science Signaling;2024-06-18

4. Research Advance on the Prevention and Treatment of Polycystic Ovary Syndrome Based on Dysbiosis of Gut Microbiota;Advances in Clinical Medicine;2024